Delivery Order SPE2DB20D1109-SPE2DB25FP32S
Award Date
7/2/25
Potential Completion Date
7/3/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,332.20 firm fixed-price contract is for the delivery of 4,568,260,604 milliliters of the drug medroxyprogesterone 150 mg/mL. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.38 contract is for the delivery of 4,568,119,737 milliliters of the medication Medroxyprogesterone 150 mg/ml. The award has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a $1,562.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,212,074 milliliters of medroxyprogesterone 150 mg/ml, a medication, with an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order (SPE2DB24FFHT7) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565520133 - MEDROXYPROGESTERONE 150 MG/ML. The contract is a firm-fixed-price delivery order with a ceiling value of $3,041.80 and an ultimate completion date of August 21, 2024. The award was made on August 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,488.88, is a Firm Fixed Price Delivery Order for the supply of Medroxyprogesterone 150 mg/mL. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,584.08 firm-fixed-price delivery order is for the supply of 4566764107 MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a period of performance through December 20, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,019.62 firm fixed price contract is for the delivery of medroxyprogesterone 150 mg/ml, a pharmaceutical product. The contract has a completion date of January 22, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related distribution...
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUQL9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,061.04 firm fixed-price delivery order is for the supply of 4567021473 MEDROXYPROGESTERONE 150 MG/ML. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency awarded a $12,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 150 mg/ml medroxyprogesterone. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the DLA under a one-day contract spanning August 24-25, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the order from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified....
This federal contract award, with ID SPE2DB22D1202|SPE2DB24FVBL1, was granted to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,030.56 Firm Fixed Price Delivery Order contract is for the provision of 4564712064 units of Medroxyprogesterone 150 mg/mL. The contract has no set-aside designation and is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that...